Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunologic alterations in patients with prostatic carcinoma.

S Brosman, M Hausman, S Shacks

    The Journal of Urology
    |June 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Arthroscopic treatment of lateral epicondylitis: clinical and cadaveric studies.

    Clinical orthopaedics and related research·2005
    Same author

    Latissimus dorsi tendon transfer for massive rotator cuff tears: a cadaveric study.

    Journal of shoulder and elbow surgery·2003
    Same author

    Hepatitis C virus infection in renal failure patients in the absence of anti-hepatitis C virus antibodies.

    Journal of viral hepatitis·2002
    Same author

    Effect of anti-IL-6 and anti-10 monoclonal antibodies on the suppression of the normal T lymphocyte mitogenic response by steady state sickle cell disease sera.

    Immunological investigations·2001
    Same author

    Novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia of chronic disease associated with cancer.

    British journal of cancer·2001
    Same author

    Distal biceps repair: a consistent and safe approach to the radial tuberosity.

    Orthopedics·2001
    Same journal

    Editorial Comment.

    The Journal of urology·2026
    Same journal

    Editorial Comment.

    The Journal of urology·2026
    Same journal

    Editorial Comment.

    The Journal of urology·2026
    Same journal

    Uro-Science.

    The Journal of urology·2026
    Same journal

    Editorial Comment.

    The Journal of urology·2026
    Same journal

    Editorial Comment.

    The Journal of urology·2026
    See all related articles

    Cell-mediated immunity is impaired in prostate cancer patients, particularly those with advanced disease. Monocyte function and inflammatory responses show significant defects, improving after surgery in some localized cases.

    Area of Science:

    • Immunology
    • Oncology

    Background:

    • Cell-mediated immunity plays a crucial role in cancer surveillance and response.
    • Prostate carcinoma can significantly impact immune function, affecting patient prognosis.

    Purpose of the Study:

    • To evaluate cell-mediated immunity in patients with prostate carcinoma.
    • To assess the correlation between immune status and disease stage.
    • To investigate the impact of treatment on immune responses.

    Main Methods:

    • Assessed delayed cutaneous hypersensitivity using dinitrochlorobenzene and recall antigens.
    • Measured inflammatory response to croton oil.
    • Quantified monocyte chemotactic response in vitro.
    • Compared immune function between localized and metastatic disease groups.

    Related Experiment Videos

    Main Results:

    • Monocyte chemotactic response was significantly depressed in prostate cancer patients compared to controls.
    • Metastatic prostate cancer exhibited a greater defect in monocyte chemotactic response than localized disease.
    • Delayed cutaneous hypersensitivity and inflammatory responses to croton oil were impaired and correlated with clinical stage.
    • Monocyte chemotactic response showed improvement after radical prostatectomy in localized disease patients.

    Conclusions:

    • Prostate carcinoma significantly impairs cell-mediated immunity, with defects correlating to disease progression.
    • Immune function, particularly monocyte chemotaxis, may serve as a biomarker for disease status and treatment response.
    • Restoration of immune function post-surgery suggests potential for therapeutic intervention.